Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety and efficacy of MEDI6012 in acute ST-elevation myocardial infarction has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• MEDI6012

Snippet

Sponsor: MedImmune LLC | Conditions: ST Elevation Myocardial Infarction | Phase 2 | Status: COMPLETED | Results posted: 2022-02-09